Abstract
Diminished left frontotemporal connectivity is among the most frequently reported findings in schizophrenia and there is evidence that altered neuronal myelination may in part account for this deficit. Several investigations have suggested that variations of the genes that encode the Neuregulin 1 (NRG1)–ErbB4 receptor complex are associated with schizophrenia illness. As NRG1-–ErbB4 has been implicated in neuronal myelination, we investigated with diffusion tensor imaging (DTI) whether fractional anisotropy (FA)—a putative measure of neuronal myelination—is predicted by a risk haplotype of the ErbB4 gene. The effects of the ErbB4 genotype were investigated in healthy subjects (N=59; mean age: 22.6±1.8 years). We also measured reaction time (RT) during a selective attention/working memory paradigm (visual oddball). In the schizophrenia risk genotype group, we found lower FA in the temporal lobe white matter (WM) including frontotemporal fiber tracts, predominantly in the left hemisphere. RT was increased in the risk genotype group and correlated with FA in the affected brain region. As FA is considered to index structural integrity of WM, to which neuronal fiber myelination is contributing, our results suggest that variations of the ErbB4 genotype may confer risk for schizophrenia illness via its impact on left frontotemporal connectivity in human brain. Reliability and validity of the result is suggested by our observation that (1) the FA–genotype association was not only obtained in the entire sample but also in both the split halves and (2) a statistical relationship was found among RT, genotype and FA.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Addington AM, Gornick MC, Shaw P, Seal J, Gogtay N, Greenstein D et al (2007). Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry 12: 195–205.
Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID et al (2004). Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7: 1319–1328.
Ashburner J, Friston KJ (2000). Voxel-based morphometry—the methods. Neuroimage 11: 805–821.
Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
Casanova R, Srikanth R, Baer A, Laurienti PJ, Burdette JH, Hayasaka S et al (2007). Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 34: 137–143.
Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS (2008). Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100: 270–280.
Corfas G, Roy K, Buxbaum JD (2004). Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7: 575–580.
Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR et al (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60: 443–456.
Eto K, Eda K, Kanemoto S, Abe S (2006). The immunoglobulin-like domain is involved in interaction of Neuregulin1 with ErbB. Biochem Biophys Res Commun 350: 263–271.
Filbey FM, Toulopoulou T, Morris RG, McDonald C, Bramon E, Walshe M et al (2008). Selective attention deficits reflect increased genetic vulnerability to schizophrenia. Schizophr Res 101: 169–175.
Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G (2001). Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 56: 304–311.
First MB, Spitzer RL, Gibbon M, Williams JBW (1995). The structural clinical interview for DSM-IV Axis I Disorders Research Version (SCID-I). American Psychiatric Press: New York.
Fox IJ, Kornblum HI (2005). Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions. J Neurosci Res 79: 584–597.
Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Moller HJ (1998). Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia. Eur Arch Psychiatry Clin Neurosci 248: 307–313.
Gur RE, Turetsky BI, Loughead J, Snyder W, Kohler C, Elliott M et al (2007). Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. Am J Psychiatry 164: 442–449.
Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746–4751.
Harrison PJ, Law AJ (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60: 132–140.
Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40–68.
Hof PR, Haroutunian V, Friedrich VL, Byne W, Buitron C, Perl DP et al (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53: 1075–1085.
Huppi PS, Dubois J (2006). Diffusion tensor imaging of brain development. Semin Fetal Neonatal Med 11: 489–497.
Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajos M (2008). Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 7: 68–83.
Kaiser S, Roth A, Rentrop M, Friederich HC, Bender S, Weisbrod M (2008). Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain Cogn 66: 73–82.
Kaplan E, Fein D, Morris R, Delis D (1991). WAIS-R as a Neuropsychological Instrument. The Psychological Corporation: New York.
Konrad A, Winterer G (2008). Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull 34: 72–92.
Kuroki N, Kubicki M, Nestor PG, Salisbury DF, Park HJ, Levitt JJ et al (2006). Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry 60: 22–31.
Law AJ, Kleinman JE, Weinberger DR, Weickert CS (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 16: 129–141.
Liu Y, Tao YM, Woo RS, Xiong WC, Mei L (2007). Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons. Biochem Biophys Res Commun 354: 505–510.
Lopez-Bendito G, Cautinat A, Sanchez JA, Bielle F, Flames N, Garratt AN et al (2006). Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 125: 127–142.
McIntosh AM, Moorhead TW, Job D, Lymer GK, Munoz Maniega S, McKirdy J et al (2007). The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry. (in press). (originally published online Oct. 9, 2007, at http://www.nature.com/mp/journal/vaop/ncurrent/abs/4002103a.html).
Mei L, Xiong WC (2008). Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9: 437–452.
Minami T, Nobuhara K, Okugawa G, Takase K, Yoshida T, Sawada S et al (2003). Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology 47: 141–145.
Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PC (2005). MRI Atlas of Human White Matter. Elsevier Ltd: Oxford.
Munafo MR, Attwood AS, Flint J (2008). Neuregulin 1 genotype and schizophrenia. Schizophr Bull 34: 9–12.
Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE et al (2006). Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry 11: 1062–1065.
Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM et al (2006). Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141: 96–101.
Papadakis NG, Xing D, Houston GC, Smith JM, Smith MI, James MF et al (1999). A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Imaging 17: 881–892.
Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN et al (1999). Structural maturation of neural pathways in children and adolescents: in vivo study. Science 283: 1908–1911.
Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM et al (2007). Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA 104: 8131–8136.
Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G (2006). Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127: 185–197.
Schmithorst VJ, Holland SK, Dardzinski BJ (2008). Developmental differences in white matter architecture between boys and girls. Hum Brain Mapp 9: 696–710.
Schmucker J, Ader M, Brockschnieder D, Brodarac A, Bartsch U, Riethmacher D (2003). ErbB3 is dispensable for oligodendrocyte development in vitro and in vivo. Glia 44: 67–75.
Shin YW, Kim DJ, Ha TH, Park HJ, Moon WJ, Chung EC et al (2005). Sex differences in the human corpus callosum: diffusion tensor imaging study. Neuroreport 16: 795–798.
Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R (2006). The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 141: 142–148.
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE et al (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487–1505.
Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S et al (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10: 631–636.
Szeszko PR, Robinson DG, Ashtari M, Vogel J, Betensky J, Sevy S et al (2008). Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33: 976–984.
Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, Falls DL et al (2008). Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 56: 284–293.
Tewes U (1991). Hamburg-Wechsler-Intelligenztest für Erwachsene. HAWIE-R. Huber: Bern.
Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R et al (2007). Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 1139: 95–109.
Uranova NA, Orlovskaia DD, Vikhreva OV, Zimina IS, Rakhmanova VI (2001). Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestn Ross Akad Med Nauk 7: 42–48.
van Haren NE, Bakker SC, Kahn RS (2008). Genes and structural brain imaging in schizophrenia. Curr Opin Psychiatry 21: 161–167.
Wang XD, Su YA, Guo CM, Yang Y, Si TM (2008). Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 11: 553–561.
Winterer G, Coppola R, Egan MF, Goldberg TE, Weinberger DR (2003). Functional and effective frontotemporal connectivity and genetic risk for schizophrenia. Biol Psychiatry 54: 1181–1192.
Winterer G, Hariri AR, Goldman D, Weinberger DR (2005). Neuroimaging and human genetics. Int Rev Neurobiol 67: 325–383.
Winterer G, Konrad A, Vucurevic G, Musso F, Stoeter P, Dahmen N (2008). Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. Neuroimage 40: 712–718.
Yakovlev PI, Lecours AR (1967). The myelogenetic cycles of regional maturation of the brain. In: Minkowski A (ed). Regional Development of the Brain in Early Life. Blackwell: Oxford. pp 3–65.
Zinkstok J, Schmitz N, van Amelsvoort T, Moeton M, Baas F, Linszen D (2008). Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain Behav 7: 61–69.
Acknowledgements
We thank W. Hoeppner (Bioglobe GmbH, Hamburg, Germany) for genetic typing service. We also thank C. Schaeffner and M. Jahnke (Department of Psychiatry and Psychotherapy, Johannes Gutenberg University, Mainz, Germany) for technical and organizational support and S. Bauer and R. Radkowa for the neuropsychological investigations.
Author information
Authors and Affiliations
Corresponding author
Additional information
DISCLOSURE/CONFLICT OF INTEREST
All authors report no competing interests.
Rights and permissions
About this article
Cite this article
Konrad, A., Vucurevic, G., Musso, F. et al. ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain. Neuropsychopharmacol 34, 641–650 (2009). https://doi.org/10.1038/npp.2008.112
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2008.112
Keywords
This article is cited by
-
GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia
Neuroscience Bulletin (2020)
-
ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children
Brain Imaging and Behavior (2015)
-
Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds
Translational Psychiatry (2014)
-
Applying Imaging Genetics to ADHD: the Promises and the Challenges
Molecular Neurobiology (2014)
-
Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
BMC Neurology (2013)
